Hikma Expecting Slow Growth In 2010 Sales

Jordan's major generic drugmaker Hikma has announced that it plans to increase sales to the 'low teens' from 10% in 2009. Despite its expansion plans within the Middle East, the growth will come from the increasing demand for prescription medicines in Western-style therapeutic areas including cardiovascular, diabetes and hypertension drugs.

To read the full article, please choose one of the following options: